Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Marex Group LtdMRX · Entity 9106 | Director · Chief Financial Officer | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Marex Group Ltd
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 31,046 |
Last balance in matching sequence
After 2026-08-14 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-08-14 · Sale · Disposed 3,500 · Balance 31,246 F1: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.69 to $71.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Row 2 · 2026-08-14 · Sale · Disposed 200 · Balance 31,046 F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.71 to $72.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.69 to $71.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.71 to $72.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 200 | $71.87 | $14,373.00 |
DisclosureSEC source: 0001193125-26-355407 · ownership.xml · nonDerivative · entry 2 Irvin Rob · CIK 0002058610 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,046 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.71 to $72.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | SaleOrdinary Shares | 3,500 | $70.91 | $248,172.40 |
DisclosureSEC source: 0001193125-26-355407 · ownership.xml · nonDerivative · entry 1 Irvin Rob · CIK 0002058610 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,246 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.69 to $71.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | Tax withholdingOrdinary Shares | 3,358 | $54.45 | $182,843.10 |
DisclosureSEC source: 0001193125-26-241871 · ownership.xml · nonDerivative · entry 1 Irvin Rob · CIK 0002058610 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,746 F1 · shares: Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported shares underlying deferred bonus plan awards. F2 · price: The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on May 21, 2026. F3 · balance_after: The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.